GoPrime: Development of an In Silico Framework to Predict the Performance of Real-Time PCR Primers and Probes Using Foot-and-Mouth Disease Virus as a Model.
PCR
diagnostics
foot-and-mouth disease
in silico modeling framework
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
20 Apr 2020
20 Apr 2020
Historique:
received:
21
02
2020
revised:
07
04
2020
accepted:
16
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
25
4
2020
Statut:
epublish
Résumé
Real-time PCR (rPCR) is a widely accepted diagnostic tool for the detection and quantification of nucleic acid targets. In order for these assays to achieve high sensitivity and specificity, primer and probe-template complementarity is essential; however, mismatches are often unavoidable and can result in false-negative results and errors in quantifying target sequences. Primer and probe sequences therefore require continual evaluation to ensure they remain fit for purpose. This paper describes the development of a linear model and associated computational tool (GoPrime) designed to predict the performance of rPCR primers and probes across multiple sequence data. Empirical data were generated using DNA oligonucleotides (n = 90) that systematically introduced variation in the primer and probe target regions of a diagnostic assay routinely used to detect foot-and-mouth disease virus (FMDV); an animal virus that exhibits a high degree of sequence variability. These assays revealed consistent impacts of patterns of substitutions in primer and probe-sites on rPCR cycle threshold (C
Identifiants
pubmed: 32326039
pii: pathogens9040303
doi: 10.3390/pathogens9040303
pmc: PMC7238122
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Department for Environment, Food and Rural Affairs
ID : SE1129
Organisme : The Pirbright Institute
ID : Business Development Fund
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007036
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Tetracore Inc
ID : PhD studentship
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007037
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007035, BBS/E/I/00007036 and BBS/E/I/00007037
Pays : United Kingdom
Références
Clin Microbiol Rev. 2006 Jan;19(1):165-256
pubmed: 16418529
BMC Biotechnol. 2009 Aug 28;9:75
pubmed: 19715565
Ann Clin Microbiol Antimicrob. 2008 Sep 25;7:18
pubmed: 18817537
J Am Vet Med Assoc. 2002 Jun 1;220(11):1636-42
pubmed: 12051502
Mol Cell Probes. 2006 Oct;20(5):311-6
pubmed: 16704921
J Microbiol Methods. 2009 Mar;76(3):316-9
pubmed: 19135484
PLoS One. 2015 Aug 13;10(8):e0135559
pubmed: 26270532
Nucleic Acids Res. 2002 Oct 15;30(20):e111
pubmed: 12384613
Nucleic Acids Res. 1990 Feb 25;18(4):999-1005
pubmed: 2179874
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
J Virol Methods. 2007 Jul;143(1):81-5
pubmed: 17397937
J Virol Methods. 2014 Oct;207:146-53
pubmed: 25016065
J Virol Methods. 2018 Feb;252:37-41
pubmed: 29113733
J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):8-20
pubmed: 11176264
Vet Microbiol. 2009 Oct 20;139(1-2):1-23
pubmed: 19497689
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13910-3
pubmed: 10570172
Appl Environ Microbiol. 2008 Mar;74(5):1660-3
pubmed: 18192413
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Nucleic Acids Res. 1992 Sep 11;20(17):4567-73
pubmed: 1408758
J Clin Virol. 2005 Oct;34(2):104-7
pubmed: 16157260
J Clin Virol. 2010 Jun;48(2):91-5
pubmed: 20413345
Gene. 1985;40(1):1-8
pubmed: 3912262
Nucleic Acids Res. 1997 Feb 1;25(3):654-8
pubmed: 9016609
Nucleic Acids Res. 2002 Mar 15;30(6):1292-305
pubmed: 11884626
J Mol Diagn. 2010 Jan;12(1):109-17
pubmed: 19948821
J Virol Methods. 2016 Nov;237:114-120
pubmed: 27575682
PCR Methods Appl. 1993 Dec;3(3):S18-29
pubmed: 8118393